Literature DB >> 25470661

Illinois Breast and Cervical Cancer Program: Implementing Effective Public-Private Partnerships to Assure Population Health.

Arden S Handler1, Vida A Henderson, Amy Rosenfeld, Kristin Rankin, Brenda Jones, L Michele Issel.   

Abstract

With the implementation of the Affordable Care Act (ACA), it is essential for the public health sector to elucidate its role with respect to its mission of assuring population health, and to clarify its role with respect to the private health care system. To that end, we examined the value added to the population health enterprise of successful public-private partnerships (PPPs) such as those found in the Illinois Breast and Cervical Cancer Program (IBCCP), the Centers for Disease Control and Prevention's (CDC's) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in Illinois. Key Informant (KI) interviews focused on IBCCP implementation were conducted with IBCCP lead agency (LA) program coordinators (n = 35/36) in winter 2012-2013. Analysis was conducted using Atlas.ti software. The KI interviews revealed the existence of highly developed PPPs between the IBCCP LAs and individual medical providers and hospitals across Illinois. The data suggest that the small amount of funding provided by IBCCP to each LA in Illinois has been used to build and sustain robust PPPs in the majority of the IBCCP communities. The PPPs developed through the IBCCP can be seen as an unplanned benefit of CDC's investment in breast and cervical health through the NBCCEDP. While the IBCCP/NBCCEDP might be considered a "boutique" categorical program which some may consider no longer necessary as individuals gain insurance under the ACA, the KI data underscore the critical role of public sector dollars, not only to serve individuals and communities directly but also to mobilize the private health care sector to act in partnership with public entities and become advocates for underserved communities.

Entities:  

Mesh:

Year:  2015        PMID: 25470661     DOI: 10.1097/PHH.0000000000000191

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  5 in total

1.  MicroRNA-432 is downregulated in cervical cancer and directly targets FN1 to inhibit cell proliferation and invasion.

Authors:  Shanzong Wang; Baohong Gao; Hailin Yang; Xuejian Liu; Xia Wu; Weijuan Wang
Journal:  Oncol Lett       Date:  2019-05-27       Impact factor: 2.967

2.  miR-494 inhibits cervical cancer cell proliferation through upregulation of SOCS6 expression.

Authors:  Lei Cheng; Beihua Kong; Ying Zhao; Jie Jiang
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

3.  Public-private partnerships in primary health care: a scoping review.

Authors:  Nasrin Joudyian; Leila Doshmangir; Mahdi Mahdavi; Jafar Sadegh Tabrizi; Vladimir Sergeevich Gordeev
Journal:  BMC Health Serv Res       Date:  2021-01-04       Impact factor: 2.655

4.  miR-185-3p targets Annexin-A8 to inhibit proliferation in cervical cancer cells.

Authors:  Wenfang Zhang; Dongyan Han
Journal:  Cytotechnology       Date:  2021-06-08       Impact factor: 2.040

5.  Long Noncoding RNA ZFPM2-AS1 Enhances the Malignancy of Cervical Cancer by Functioning as a Molecular Sponge of microRNA-511-3p and Consequently Increasing FGFR2 Expression.

Authors:  Jun Dai; Rujia Wei; Peihai Zhang; Peishu Liu
Journal:  Cancer Manag Res       Date:  2020-01-23       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.